Vimarsana
Biggest News Aggregation in the World

Derrell Porter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Derrell Porter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Derrell Porter Today - Breaking & Trending Today

Passage Bio : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K -December 29, 2023 at 04:19 pm EST - Vimarsana News

Passage Bio : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K -December 29, 2023 at 04:19 pm EST

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE TARA M. WILLIAMS, derivatively on behalf of PASSAGE BIO, INC., ...

cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer - Vimarsana News

cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer

/PRNewswire/ -- cTRL Therapeutics, a biotechnology company harnessing circulating tumor-reactive lymphocytes (cTRLs) in the blood to broaden the power and...

Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2022 and Business Highlights - Vimarsana News

Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2022 and Business Highlights

INTERCEPT-AD, a Phase 1 clinical trial of ACU193 in patients with early Alzheimer’s disease, completed enrollment in February 2023 Topline data expected in the third quarter of 2023 Cash, cash... | March 27, 2023

Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to - Vimarsana News

Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to

CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a...

Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors - Vimarsana News

Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors

CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 -- Acumen Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel targeted therapeutics for... | January 4, 2023